Basecamp unveils six-program therapeutics pipeline
1 Today 9:25 AM · 13h ago · 4 articles · 1 source · development 1 of 2
Endpoints News reported that alongside the funding announcement, Basecamp disclosed a six-program pipeline as a test of its AI platform, and the company appointed former Biogen executive Richard Pearce as Chief Business Officer to expand pharma partnerships.
“We believe the future of medicine lies in reprogramming the body to repair itself. We design the models and the medicines to teach it how.”
Glen Gowers, Co-founder and CEO, Basecamp Research · techmeme ↗Glen Gowers Co-founder and CEO of Basecamp ResearchOliver Vince Co-founder of Basecamp ResearchPhilip Lorenz CTO of Basecamp ResearchAndy Conrad General Partner at S32, new board memberAnthropic Investor via its Anthology Fund
The whole story articles the bright band is this development · numbered dots are the others · click one to jump
What was reported 1 claim about this development
-
first by Endpoints News, 13h ago
What people said 1 voice · verbatim
-
A UK startup has just raised $140m to design new medicines with AI. The London startup is founded by @glen_gowers and Oliver Vince, and just announced their $140m Series C led by S32, with NVIDIA and Anthropic joining as new investors as well. Basecamp Research is teaching AI to understand biolog...
All 2 developments of Basecamp Research raises $140M Series C at $800M valuation… →
NewswiresX